Literature DB >> 26429667

Addition of lipids to parenteral nutrition does not cause fungal infections.

Krishnan Sriram1, Michael M Meguid2.   

Abstract

Parenteral nutrition (PN) that includes lipid emulsion is considered to increase both bacterial and fungal central venous catheter-related bloodstream infections. This concept is based on several erroneous metrics: Reports in age-old literature at a time when preparing PN admixtures lacked stringent quality control, when its infusion, the techniques of insertion, maintenance of vascular access devices, and delivery systems were not well identified or enforced. Additionally, concepts of glucohomeostasis were different and higher glucose levels were accepted. We provide updated information with supporting literature to show that associating PN with lipids with an increase in bloodstream infections is not justified. Published by Elsevier Inc.

Entities:  

Keywords:  Bloodstream infections; Candidemia; Fungal infections; Lipid emulsions; Lipids; Parenteral nutrition

Mesh:

Substances:

Year:  2015        PMID: 26429667     DOI: 10.1016/j.nut.2015.05.010

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  3 in total

1.  Disparate Candida albicans Biofilm Formation in Clinical Lipid Emulsions Due to Capric Acid-Mediated Inhibition.

Authors:  Hubertine M E Willems; Jeremy S Stultz; Molly E Coltrane; Jabez P Fortwendel; Brian M Peters
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

Review 2.  Lipid-Enriched Parenteral Nutrition and Bloodstream Infections in Hospitalized Patients: Is It a Real Concern?

Authors:  Antonio Tota; Amato Serra; Pauline Raoul; Antonio Gasbarrini; Emanuele Rinninella; Maria Cristina Mele
Journal:  Medicina (Kaunas)       Date:  2022-07-01       Impact factor: 2.948

3.  Case report: nosocomial fungemia caused by Candida diddensiae.

Authors:  Seong Eun Kim; Sook In Jung; Kyung-Hwa Park; Yong Jun Choi; Eun Jeong Won; Jong Hee Shin
Journal:  BMC Infect Dis       Date:  2020-05-27       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.